Ozawa H, Higuchi T, Fujimoto Y, Bun A, et al. Total Lesion Glycolysis Levels as Predictive Indicators in Patients With Metastatic and Recurrent Breast Cancer Undergoing Endocrine Therapy With or Without CDK4/6 Inhibitor. Anticancer Res 2022;42:4813-4824.
PMID: 36191999